Business · Companies · 8 hrs ago
Vale Biolabs receives €164,000 to advance brain disease research
Vale Biolabs received €164,000 from Venture Kick to advance its brain disease research platform.
The startup was founded by Ilaria Incaviglia, Angeliki Damilou, Daniel Medina Cano and Theodoulos Rodosthenous.
Its platform uses lab-grown human brain tissue, automation and predictive AI to study how the brain responds to potential treatments.
Neurological drug research often relies on animals, but differences between animal and human biology can make it hard to predict how a treatment will work in people.
Vale Biolabs aims to test treatments on human brain models earlier, potentially helping researchers spot promising drugs or problems before clinical trials.
The funding will support platform development, expanded brain tissue models, AI training data and work with research and industry partners.
Vale Biolabs has received €164,000 from Venture Kick to advance its platform for studying brain diseases and evaluating potential treatments.
The startup combines lab-grown human brain tissue, automation and predictive AI to help researchers study how the brain responds to drugs.
Its platform uses standardised human brain organoids and tracks their structural, activity and molecular changes after exposure to potential treatments.
Venture Kick’s funding will support platform development, expanded organoid models, AI datasets and collaborations with research and industry partners.
The company aims to help identify promising therapies and potential failures earlier in drug development.
- Who
- Vale Biolabs, a biotech startup, received the funding from Venture Kick.
- What
- It received €164,000 to advance a platform for studying brain diseases and evaluating potential treatments.
- When
- 2026-11-09, the article’s publication date.
- Where
- Not stated.
- Why
- To develop the automated platform, expand human brain organoid models, generate AI training and validation datasets, and advance collaborations.
This story does not have two clearly opposing sides.
This story does not have a timeline yet.
- Funding
- €164,000 (CHF 150,000)
- Funder
- Venture Kick
- Founders
- Ilaria Incaviglia, Angeliki Damilou, Daniel Medina Cano and Theodoulos Rodosthenous
- Platform
- Human brain organoids, automation and predictive AI
- Research areas
- Brain development, neurodegenerative diseases and healthy brain ageing